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Abstract 
Background 
Periodontitis results from the interaction between a subgingival biofilm and host immune response. 
Changes in biofilm composition are thought to disrupt homeostasis between the host and subgingival 
bacteria resulting in periodontal damage. Chronic systemic inflammatory disorders have been shown to 
affect the subgingival microbiota and clinical periodontal status. However, this relationship has not been 
examined in subjects with systemic lupus erythematosus (SLE). The objective of our study was to 
investigate the influence of SLE on the subgingival microbiota and its connection with periodontal disease 
and SLE activity. 
Methods 
We evaluated 52 patients with SLE compared to 52 subjects without SLE (control group). Subjects were 
classified as without periodontitis and with periodontitis. Oral microbiota composition was assessed by 
amplifying the V4 region of 16S rRNA gene from subgingival dental plaque DNA extracts. These 
amplicons were examined by Illumina MiSeq sequencing. 
Results 
SLE patients exhibited higher prevalence of periodontitis which occurred at a younger age compared to 
subjects of the control group. More severe forms of periodontitis were found in SLE subjects that had 
higher bacterial loads and decreased microbial diversity. Bacterial species frequently detected in 
periodontal disease were observed in higher proportions in SLE patients, even in periodontal healthy sites 
such as Fretibacterium, Prevotella nigrescens, and Selenomonas. Changes in the oral microbiota were 
linked to increased local inflammation, as demonstrated by higher concentrations of IL-6, IL-17, and IL-33 
in SLE patients with periodontitis. 
Conclusions 
SLE is associated with differences in the composition of the microbiota, independently of periodontal 
status. 
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Subgingival microbiota dysbiosis in
systemic lupus erythematosus: association
with periodontal status
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Gabriel R. Fernandes3, E. Xiao4, Antônio Lúcio Teixeira2, Eugene J. Leys5, Dana T. Graves4†
and Tarcília Aparecida Silva1,6*†
Abstract
Background: Periodontitis results from the interaction between a subgingival biofilm and host immune response.
Changes in biofilm composition are thought to disrupt homeostasis between the host and subgingival bacteria
resulting in periodontal damage. Chronic systemic inflammatory disorders have been shown to affect the
subgingival microbiota and clinical periodontal status. However, this relationship has not been examined in subjects
with systemic lupus erythematosus (SLE). The objective of our study was to investigate the influence of SLE on the
subgingival microbiota and its connection with periodontal disease and SLE activity.
Methods: We evaluated 52 patients with SLE compared to 52 subjects without SLE (control group). Subjects were
classified as without periodontitis and with periodontitis. Oral microbiota composition was assessed by amplifying
the V4 region of 16S rRNA gene from subgingival dental plaque DNA extracts. These amplicons were examined by
Illumina MiSeq sequencing.
Results: SLE patients exhibited higher prevalence of periodontitis which occurred at a younger age compared to
subjects of the control group. More severe forms of periodontitis were found in SLE subjects that had higher
bacterial loads and decreased microbial diversity. Bacterial species frequently detected in periodontal disease were
observed in higher proportions in SLE patients, even in periodontal healthy sites such as Fretibacterium, Prevotella
nigrescens, and Selenomonas. Changes in the oral microbiota were linked to increased local inflammation, as
demonstrated by higher concentrations of IL-6, IL-17, and IL-33 in SLE patients with periodontitis.
Conclusions: SLE is associated with differences in the composition of the microbiota, independently of periodontal status.
Keywords: Lupus, Periodontitis, Oral microbiota, Cytokine, Subgingival dental plaque, Illumina sequencing
Background
Periodontitis is a multifactorial infectious disease that af-
fects tooth supporting tissues [1]. In health, there is equi-
librium between the subgingival biofilm and the host
immune response. Periodontal bone loss is initiated when
there is a disruption that causes the inflammatory response
to move closer to the bone inducing osteoclastogenesis
and impaired osseous coupling [2]. Changes in bacterial
composition or systemic inflammation are thought to dis-
rupt the balance between host and oral microbiota leading
to destruction of periodontal tissues [3–5]. Therefore,
chronic inflammatory conditions such as diabetes, obesity,
rheumatoid arthritis (RA), and systemic lupus erythemato-
sus (SLE) are linked to an increased risk or severity of peri-
odontal disease [6–11]. Furthermore, periodontitis might
have an adverse effect by enhancing systemic inflammation
and increasing the risk of myocardial infarction [12], pre-
term birth [7], pneumonia [13], stroke [14], and rheuma-
toid arthritis [15] as well as worsen SLE severity [16].
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SLE is an autoimmune disease characterized by the
presence of aberrant antibody responses to nuclear and
cytoplasmic antigens. It is a complex multifactorial disease
in which genetic and environmental factors contribute to
disease susceptibility [17]. An environmental factor that
modulates autoimmunity is the bidirectional crosstalk
between the human host and microbiota, as reported for
rheumatic diseases [18, 19]. However, few studies have ad-
dressed the relationship between SLE and the human
microbiota [20, 21] or the periodontal condition in SLE
patients [10, 16, 22–27]. Moreover, the results have been
conflicting, due in part to small sample size.
The influence of SLE on the oral microbiota has not
been reported. To address this issue, we analyzed the
subgingival microbiota in SLE patients and healthy sub-
jects to draw potential links among systemic immune
dysregulation, subgingival microbiota, and periodontal
disease. The results indicate that SLE alters the subgingi-
val microbiota. This understanding might be useful in
delineating strategies to treat these patients and suggests
that these patients should be followed closely for peri-
odontal disease based on their altered microbiota and
enhanced susceptibly to develop periodontitis.
Results
Systemic lupus erythematosus results in higher
prevalence and severity of periodontal disease
Demographic and clinical characteristics of subjects in-
cluded in the study are presented in Table 1. Sixty-seven
percent of SLE patients had periodontitis, a significantly
higher prevalence when compared to healthy controls
(53%). The prevalence of chronic periodontitis in healthy
Brazilians is consistent with previous reports [28–30].
An interesting finding was the presence of periodontitis
at a younger age in SLE patients (40.5 ± 10.1 years) com-
pared to controls (46.3 ± 13.2, p < 0.05). In addition, 29
SLE patients were younger than 35 years, and from
these, 52% already had periodontitis (data not shown).
SLE subjects had increased probing depth and increased
loss of clinical attachment indicating more severe peri-
odontitis (Table 1). Periodontal probing depth was sig-
nificantly correlated with most of the SLE parameters
(duration of SLE rho = 0.32, accumulated dose of pred-
nisone rho = 0.36 and C-reactive protein level rho = 0.30,
p < 0.05). Moreover, loss of clinical attachment was cor-
related with duration of SLE (rho = 0.35, p < 0.05) and
the Systemic Lupus International Collaborating Clinics/
American College of Rheumatology Damage Index
(SLICC/ACR) damage index (rho = 0.32, p < 0.05).
All subjects exhibited similar oral hygiene habits (fre-
quency of tooth brushing and dental flossing per day).
No difference in smoking status between groups was
found. When evaluating oral hygiene parameters, control
subjects with periodontitis had an increased plaque
index compared to non-periodontitis subjects (p < 0.05),
but this association was not observed in SLE patients
(Table 1). It is noteworthy that when 336 SLE patients
were evaluated, 62 (24%) were excluded because they
did not have at least 8 teeth. Although it is difficult to
assess the exact cause of this early tooth loss, many
Table 1 Demographic and clinical data of patients with SLE and healthy control subjects
Controls SLE
Non-CP CP Non-CP CP
Subjects 24 (46.2%) 28 (53.8%) 17 (32.7%) 35 (67.3%)ab
Females (%) 39 48 30 57
Age (years) 34.7 (±15.9) 46.3 (±13.2)a 31.2 (±5.2) 40.5 (±10.1)ab
Smoking status (%) 3.81 7.60 5.70 9.60
SLE duration (years) – – 8.6 (±6.2) 12.5 (±7.8)a
SLEDAI – – 4.5 (±4.0) 5.5 (±4.6)
SLICC/ACR – – 0.5 (±1.0) 0.9 (±0.9)
Probing depth (mm) 1.65 (±0.31) 2.72 (±0.62)a 1.91 (±0.62) 3.37 (±0.49)ab
Clinical attachment level (mm) 2.60 (±0.24) 3.62 (±0.63)a 2.97 (±0.63) 4.00 (±0.63)ab
Bleeding upon probing (% sites) 4.67 (±7.85) 20.78(±19.5)a 7.20 (±4.70) 16.91 (±15.9)a
Plaque Index (score) 0.43 (±0.28) 0.91(±0.59)a 0.83 (±0.40) 0.88 (±0.50)
Tooth brushing (times/day) 2.85 (±0.93) 2.62 (±0.85) 3.0 (±0.76) 2.96 (±0.92)
Dental floss (times/day) 1.06 (±0.94) 0.74 (±0.89) 1.26 (±1.40) 1.38 (±1.30)
Tooth loss 1.78 (±2.17) 4.50 (±3.70)a 1.38 (±1.57) 4.90 (±4.17)a
Values were expressed as mean ± SD or percentage
Non-CP without chronic periodontitis, CP chronic periodontitis, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC/ACR Systemic Lupus
International Collaborating Clinics/American College of Rheumatology Damage Index
aStatistically different comparing Non-CP × CP within the same group
bStatistically different comparing SLE × healthy control group. Kruskal-Wallis test with Dunn’s post hoc test <0.05
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patients reported that they lost their teeth because the
teeth became “loose,” consistent with loss from
periodontitis.
SLE impacts oral microbiota diversity
To assess the factors that may lead to increased preva-
lence and severity of periodontitis in SLE patients, we
examined whether the subgingival microbiota was
altered. The bacterial load was one log higher in SLE dis-
eased sites compared to control subjects with diseased
sites (Fig. 1). In control subjects, the presence of periodon-
titis resulted in increased microbial diversity (p < 0.05),
while in SLE patients, there was decreased microbial di-
versity at diseased sites (p < 0.05) (Fig. 2a and b).
UniFrac analysis was performed to compare the degree
of phylogenetic overlap in the microbial communities in
SLE and control subjects. Beta diversity, which reflects
the relatedness of disease- and health-associated bacter-
ial populations, established that bacterial communities
from each group tended to cluster together (PERMA-
NOVA, p = 0.001) (Fig. 3). The bacterial taxa in SLE dis-
eased sites were more similar to each other than bacteria
from SLE non-periodontitis and healthy subjects’ sites,
indicating lower heterogeneity in subgingival microbial
communities in the SLE periodontitis subjects (Fig. 4).
Dysbiosis of oral microbiota in patients with SLE
We investigated the impact of SLE on the subgingival bac-
terial composition. At healthy periodontal sites in SLE pa-
tients, there were increased proportions of a member of
Lachnospiraceae family (unclassified Lachnospiraceae A
IR009) compared to healthy sites in controls (p < 0.05)
(Fig. 5a and b). In contrast, proportions of Prevotella
oulorum and Prevotella pleuritidis, Pseudomonas spp,
Treponema maltophilum, and Actinomyces IP073, bacteria
associated with disease, were elevated at periodontal dis-
ease sites in patients with SLE compared to periodontitis
sites of non-SLE controls (p < 0.05) (Fig. 5c and d). Sphin-
gomonas were at lower relative levels in healthy periodon-
tal sites of SLE patients (p < 0.05) (Fig. 5a and b) and
Rothia aeria, Capnocytophaga gingivalis, Clostridiales,
Rasltonia oral taxon 027, Leptotrichia oral taxon A71,
Streptococcus sanguinis, and Haemophilus parainfluenzae
had decreased relative abundance in periodontitis sites of
SLE group (p < 0.05) (Fig. 5c and d)
Differentially represented OTUs were analyzed via
LEfSe, a statistical measure used in metagenomic bio-
marker discovery [31] (Fig. 6). This analysis revealed that
at SLE healthy periodontal sites, species such as Prevo-
tella nigrescens, Prevotella oulorum, Prevotella oris, and
Selenomonas noxia exhibited elevated proportions
(Fig. 6a). When examining the periodontitis sites, we
found again increased relative levels of P. oulorum in
SLE patients as well as increased relative levels of Freti-
bacterium fastidiosum and Fusobacterium oral taxon
360 450, Anaeroglobus geminatus, and TM7 oral taxon
437 (Fig. 6b). Most of the bacterial species found with
elevated proportions in SLE patients were anaerobic
(Prevotella, Selenomonas, and Treponema), while in
healthy non-SLE subjects, there was an increase in the
relative abundance of predominantly aerobic species
(Rothia, Haemophilus, and Streptococcus).
Microbial intercorrelations
Since periodontitis is a polymicrobial disease, it is im-
portant to investigate correlations among subgingival
microorganisms. Fig. 7 shows the co-occurrence patterns
among bacterial species in subjects with and without
Fig. 1 Subgingival bacterial load of healthy subjects (control) and patients with Systemic Lupus Erythematosus (SLE) with chronic periodontitis
(CP) and Non-CP (NCP), determined by real-time PCR using universal primers for 16S rRNA gene. *Statistically different compared to NCP subjects
within the same group. #Statistically different compared to control subjects. p < 0.05, Kruskal-Wallis test with Dunn’s post hoc test
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Fig. 2 Alpha diversity index, a observed species and b Chao1 index of control subjects or Systemic Lupus Erythematosus patients (SLE) with
chronic periodontitis (CP) or Non-CP (NCP). *Statistically different compared to NCP subjects within the same group. #Statistically different
compared to Control group. p < 0.05, Kruskal-Wallis test with Dunn’s post hoc test. Alpha diversity metrics were calculated after subsampling to
obtain equal number of sequences per library
Fig. 3 Beta diversity. Microbiota separation on the principal coordinates calculated from unweighted UniFrac distances. a Control subjects, b SLE
patients, c non-periodontitis subjects, and d chronic periodontitis subjects
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SLE. In non-SLE subjects (Fig. 7a), we observed a total
of 89 bacterial correlations with positive relationship
among pathogenic groups (i.e., Porphyromonas gingivalis
and Selenomonas, Treponema vincentii, Fusobacterium
nucleatum, and Fretibacterium) and negative correla-
tions between pathogenic bacteria and periodontal
healthy-related species (i.e., Streptococcus mitis and
Treponema denticola and T. vincentii or between P. oris
and Haemophilus parainfluenzae).
In SLE patients, we observed a wider net of correla-
tions than in the healthy subjects, with a total of 111
correlations (Fig. 7b). Positive correlations were found
among periodontal pathogens (T. denticola, P. gingivalis,
Fretibacterium fastidiosum, and Tannerella forsythia)
[32]. In contrast, negative correlations were observed
among pathogenic bacteria (F. fastidiosum, P. gingivalis,
T. forsythia, T. denticola, and Prevotella intermedia) and
health-related species (H. parainfluenzae and S. mitis) in
SLE group.
Microbiota correlations with SLE index, salivary, and
serum concentration of cytokines
We investigated the relationship between bacteria and
local inflammation by measuring cytokines in saliva.
There was a significant increase in inflammatory
cytokines IL-6, IL-17, and IL-33 in saliva of SLE patients
with periodontitis compared to control group with peri-
odontitis. No significant differences in cytokine levels
were found in non-SLE subjects with periodontitis com-
pared to non-SLE subjects without periodontitis (Fig. 8).
The production of these cytokines in saliva of SLE pa-
tients was correlated with relative abundance of
Selenomonas (IL-6 rho = 0.42, IL-33 rho = 0.44, p < 0.05)
Prevotella denticola (IL-33 rho = 0.40, p < 0.05),
Veilonella atypica (IL-33 rho = 0.50, p < 0.05), and Lepto-
trichia (IL-17 rho = 0.4, p < 0.05). Leptotrichia was also
correlated with IL-17 in healthy periodontal sites from
SLE patients (rho = 0.7, p < 0.05). In the serum, there
was a significant increase in the levels of IL-6 in the SLE
patients with periodontitis, while no difference was
found in other analyzed cytokines TNF-α, IL-33, and
IFN-γ (Additional file 1: Table S1). No correlations were
observed between IL-6 and relative abundance of
bacteria.
Spearman Rank correlations were calculated to estab-
lish relationships between the relative abundance of
bacterial taxa found in subgingival sites of SLE patients
and parameters of SLE severity. Table 2 shows that six
species of Prevotella correlated with SLE disease index
and inflammatory markers. Fretibacterium oral taxon
BB62 and F. fastidiosum correlated with SLE duration,
while S. noxia correlated with CRP levels. P. gingivalis
was positively correlated with SLE duration and accumu-
lated dose of prednisone.
Discussion
The major findings of this study are that SLE patients
had a dysbiotic subgingival microbiota with higher sub-
gingival bacterial load, reduced microbial diversity, and
changes in bacterial composition with a shift toward
greater proportions of pathogenic bacteria. The results
suggest that SLE has a significant impact on periodontal
health as SLE patients have more severe periodontitis.
Reinforcing this finding, we also noticed that 24% of the
Fig. 4 The average weighted UniFrac distance values (the beta diversities) of healthy subjects (control) and patients with Systemic Lupus
Erythematosus (SLE) with chronic periodontitis (CP) and Non-CP (NCP).*Statistically different compared to NCP subjects within the same group.
#Statistically different compared to control group. p < 0.05, Kruskal-Wallis test with Dunn’s post hoc test
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initial SLE patients evaluated were excluded because
they did not have at least eight teeth. In comparison,
none of the healthy subjects were excluded for this
reason. This finding is likely to be important since peri-
odontal disease is an important cause of tooth loss in
adults [33]. Moreover, periodontal probing depth, a
measure of periodontal destruction, was correlated with
the duration of SLE, accumulated dose of prednisone
and the level of systemic inflammation measured by
serum C-reactive protein.
We found a high prevalence of periodontitis in SLE
patients, which was observed in almost 70% of these
patients, in agreement with previous studies [16, 26, 34].
In our study, the experimental and control groups were
similar regarding age and gender, ruling out these poten-
tial confounding factors [30]. Other factors may also
contribute to the premature development of periodontal
disease in SLE subjects, such as medications used to
treat SLE. However, most are anti-inflammatory drugs
consisting of steroids and immunosuppressive medica-
tions [35] that typically reduce gingival inflammation
[36, 37]. We found that the dose of prednisone was cor-
related with periodontal destruction and also with the
presence of pathogenic bacteria species such as Fretibac-
terium and P. gingivalis. Whether this is due to more
severe SLE in subjects with higher prednisone or a direct
Fig. 5 OTUs and taxa differing between non-periodontitis (upper panel) and periodontitis (lower anel) sites. a, c Heat map with the OTUs showing
a p value of less than 0.05 when comparing relative abundances between control and SLE subjects. Subjects are shown in columns, while OTUs
appear in rows. Blue asterisks indicate OTUs with decreased proportions in SLE patients, while red asterisks indicated OTUs with increased
proportions in SLE in relation to respective controls. b, d The graphic representation of differences in the relative abundances of species
represented in the heat maps
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effect of the drug is open to question. Reports that corti-
costeroids have little direct impact on the periodontium
would argue for the former [38].
Our study is the first to analyze the bacterial compos-
ition of the subgingival microbiota in SLE patients using
16S rRNA gene sequencing. This approach allowed a
comprehensive view of the subgingival microbial commu-
nities associated with SLE. We found that the bacterial
load was one log higher in SLE patients with periodontitis
compared to control subjects with periodontitis. Alter-
ations in the inflammatory status of the periodontium in-
duced by SLE may impact the subgingival bacterial
composition, which in turn may further enhance inflam-
matory changes and mediate tissue destruction in SLE
patients [39]. Consistently higher levels of IL-6, IL-17, and
IL-33 were detected in SLE patients with periodontitis.
These cytokines are increased in the serum of SLE
patients [39–43] and non-SLE individuals with inflamed
gingival tissues [44–47]. IL-33 exacerbates periodontal
disease [47], increases IL-6 expression [48], and enhances
a Th17 response [42]. IL-6 promotes activation and differ-
entiation of T cells, B cells, macrophages, neutrophils, and
osteoclasts and promotes formation of Th17 cells [49].
The levels of IL-6, IL-17, and IL-33 were positively corre-
lated with the relative abundance of pathogenic bacteria
such as Selenomonas, P. denticola, Veilonella, and Lepto-
trichia. Accordingly, increased inflammation may provide
a source of nutrients in the form of tissue breakdown
products and alter the redox environment favoring the
growth of anaerobic bacteria [3]. In turn, changes in the
microbiota might be important to amplify local inflamma-
tion and periodontal tissue damage.
SLE influenced microbial diversity, as patients with
SLE had lower diversity in sites with periodontal
breakdown compared to equivalent sites in matched
control subjects. It is possible that the lower diversity
facilitates microbial changes that increase susceptibility
to periodontitis based on findings of decreased bacterial
diversity in inflammatory diseases such as psoriatic arth-
ritis [50] and Crohn’s disease [51]. We also found that
bacteria commonly found in periodontal healthy, such as
Capnocytophaga [52–56], Rothia [54, 56–58], H. parain-
flunzae [56, 59], and Streptococcus [60] were reduced in
proportional abundance in SLE patients with periodon-
titis, and bacterial species frequently detected in peri-
odontal disease were observed in higher proportions in
SLE patients, even in periodontal healthy sites (i.e., Pre-
votella oulorum, P. nigrescens, P. oris, S. noxia, and Lep-
totrichia). In addition, bacterial samples from diseased
sites in subjects with SLE were more similar to each
other than bacterial samples from healthy sites. Shi et al.
[61] also found that bacteria from periodontal disease
sites were more similar to each other than bacteria from
healthy sites. This was observed in different sites within
an individual and in comparison to sites between indi-
viduals. These findings suggest that the ecological envir-
onment is more consistent and similar in disease than in
healthy conditions.
The subgingival microbial community in the SLE
patients differs not only in the taxonomic composition
but also in the co-occurrence patterns of periodontal mi-
croorganisms. Co-occurrence analysis indicates that in
the SLE patients, the presence of pathogenic bacteria
was positively correlated with other pathogenic bacteria
(T. denticola, P. gingivalis, T. forsythia, and F. fastidio-
sum) [32]. Shi et al. similarly reported that periodontitis-
associated microorganisms were highly correlated in the
diseased state but poorly correlated after treatment,
Fig. 6 OTUs with different relative abundance in control subjects (red) and SLE samples (green) in non-periodontitis (a) and chronic periodontitis
subjects (b). Graph depicts OTUs with different relative abundance based on LEfSe results. Bars represent linear discriminant analysis scores (LDA)
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suggesting that there are coordinated interactions among
the pathogenic microorganisms. It is possible that SLE
favors bacterial interactions that lead to increased peri-
odontal disease.
Periodontal disease in SLE patients shows distinct fea-
tures compared to systemic healthy subjects. SLE may
disrupt the balance between host and microbiota in
favor of a dysbiotic condition, resulting in increased
periodontal damage or an enhanced inflammatory re-
sponse leading to an increased risk of periodontitis. It is
also possible that periodontitis aggravates SLE disease
severity, as a worsened periodontal condition was corre-
lated with increased systemic inflammation in subjects
with SLE. This result is consistent with reports that peri-
odontal treatment improves clinical outcomes in rheum-
atic diseases such as rheumatoid arthritis and SLE [16,
26, 62, 63]. Moreover, increases in the proportion of
some subgingival bacteria such as P. nigrescens has been
related to preterm birth [64], rheumatoid arthritis [9, 65,
66], and atherosclerosis [67]. In our study P. nigrescens
Fig. 7 Correlations among bacteria species in control (a) and SLE subjects (b) with chronic periodontitis (CP) (green) and Non-CP (NCP) (yellow). In
white area are the bacteria that are common to subjects with CP and NCP. Spearman Rank test with a cutoff rho value of 0.4 and p < 0.05. Blue
lines indicate positive correlations and red lines negative correlations
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was correlated to higher values of SLE index (SLEDAI
and SLICC/ACR), P. denticola with increased neutrophil
levels, and Prevotella melaninogenica with increased
serum CRP levels in SLE patients. Other studies in
rheumatoid arthritis have found that Prevotella species
[52, 68] and A. geminatus [52] were found in higher
levels in RA patients than in healthy controls. These re-
sults suggest a possible two-way cycle in which systemic
inflammation enhanced by SLE induces dysbiosis of the
subgingival microbiota and progression to periodontitis.
Periodontitis may then affect the systemic immune
response, leading to increased activity of SLE [69].
The present study represents the first comprehensive
evaluation of the subgingival microbiota associated with
periodontal status in SLE patients and provides a strong
basis for further study on the relationship between the
two diseases. As a cross-sectional study, the present
work has limitations as it is not able to define cause and
effect relationship. A longitudinal study in which the
same individual was followed just after SLE diagnosis
could provide evidence for a cause and effect relation-
ship between the two diseases. This would be particu-
larly useful in identifying bacterial changes associated
with the onset of periodontal disease in SLE patients. An
intervention trial in which patients are treated for peri-
odontitis would further enhance our understanding as to
whether periodontitis has an impact of SLE disease
severity.
Conclusions
SLE patients exhibit a higher prevalence of periodontal
disease and increased periodontal disease severity. SLE
patients had increased local inflammation and an altered
subgingival microbiota, which may account, in part for
the periodontal changes. Periodontal inflammation was
also associated with more severe SLE scores. The results
point to the need to closely monitor the periodontal
health of subjects with SLE and for periodontal
Fig. 8 Concentration of IL-6 (a), IL-17 (b), and IL-33 (c) in saliva of healthy subjects (control) and patients with Systemic Lupus Erythematosus
(SLE) with chronic periodontitis (CP) and Non-CP (NCP). Cytokine measurement was determined by CBA and ELISA, and values were normalized
by stimulated salivary flux.*Statistically different compared to NCP subjects within the same group. #Statistically different compared to healthy
subjects with CP. p < 0.05, Kruskal-Wallis test with Dunn’s post hoc test
Table 2 Correlations among SLE parameters and relative abundance of bacteria species in subjects with chronic periodontitis
(rho values)
SLICC SLEDAI SLE duration
(years)
Accumulated dose
of prednisone (mg)
CRP Neutrophils Lymphocytes
(mg/L) (cells/mm3) (cells/mm3)
Prevotella nigrescens 0.56* 0.40* – – – – –
Prevotella oris – – 0.45* – – – –
Prevotella denticola – – – – – 0.44* –
Prevotella melaninogenica – – – – 0.44* – –
Prevotella oulorum – – – – – – 0.56*
Fretibacterium oral taxon BB62 – – 0.51* 0.75* – – –
Fretibacterium fastidium – – 0.40* – – – –
Selenomonas noxia – – – – 0.50* – –
Porphyromonas gingivalis – – 0.68* 0.48* – – –
SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC/ACR Systemic Lupus International Collaborating Clinics/American College of Rheumatology
Damage Index, CRP C-reactive protein
*Spearman rank correlation, p < 0.05
Corrêa et al. Microbiome  (2017) 5:34 Page 9 of 13
treatment at early stages, including the removal of sub-
gingival dental plaque.
Methods
Subjects
Three hundred thirty-six patients diagnosed with SLE
(according to ACR 1982/1997 revised classification cri-
teria) from Rheumatology Outpatient Clinic of Clinics
Hospital of Federal University of Minas Gerais (UFMG),
Belo Horizonte, Brazil, were initially evaluated. Based on
a power analysis at alpha=1 and 5%, 50 subjects will
reach a power of 99% when comparing bacterial taxa fre-
quencies between subgingival samples as reported by La
Rosa et al. [70]. Fifty-two patients were included in the
study after matched the inclusion criteria: Subjects in-
cluded were at least 18 years of age, no other rheumatic
diseases (except for secondary Sjögren syndrome), no
treatment for periodontal disease within the last
6 months, no use of orthodontic appliances, no use of
antibiotics within the last 3 months, no need for antibi-
otics for infective endocarditis prophylaxis during dental
procedures, no chronic renal insufficiency requiring
dialysis or after kidney transplantation, pregnancy or lac-
tation, no acute or chronic infectious conditions at the
time of the study visit, no diagnosis of neoplastic disease
within the last 5 years, and the presence of at least eight
teeth. Additionally, we have excluded from the study
patients that did not agree to participate, did not under-
stand the study, or decided to leave the study after the
first clinic visit. SLE group was matched for age and
gender with 52 subjects without SLE or other known
rheumatic diseases (control group).
Medical records were collected for SLE parameters, Sys-
temic Lupus Erythematosus Disease Activity Index 2000
(SLEDAI 2 K) measured SLE activity [71] and Systemic
Lupus International Collaborating Clinics/American Col-
lege of Rheumatology Damage Index (SLICC/ACR) evalu-
ated SLE-associated damage [72]. Periodontal status was
assessed by two calibrated examiners. The following
parameters were recorded: plaque index, probing depth
(PD), clinical attachment level (CAL), and bleeding on
probing (BOP). Periodontitis was defined as the presence
of two or more interproximal sites with probing depth
≥4 mm or one site with probing depth ≥5 mm [73].
Sample collection
Subgingival dental plaque samples were collected as de-
scribed elsewhere [14]. Sterile endodontic paper points
(ISO40) (Tanariman, Manacaparu, AM, Brazil) were
inserted in the five sites with deepest periodontal
pockets and kept there for 1 min. All paper points with
subgingival plaque samples were pooled together. After
removal, the material was stored in a sterile tube con-
taining 500 μL of sterile distilled water and centrifuged
at ×3000g for 5 min. The paper points were discharged,
and the pellet was kept at −80 °C until DNA extraction.
For saliva collection, patients could not eat or drink an
hour before collection procedure. They washed the mouth
with pure water and swallowed whole saliva before collec-
tion. Saliva was collected by continuous drool into a sterile
50 mL tube for 5 min. The non-stimulated salivary flow
was measured in milliliters per minute (ml/min). The saliva
samples were subsequently diluted (1:1) in a phosphate-
buffered saline (PBS) solution containing protease inhibi-
tors and subsequently frozen at −80 °C until analysis.
Blood samples were collected using a vacutainer with
EDTA and immediately placed on ice, clarified by centri-
fugation at ×3000g for 5 min at 4 °C, and kept frozen at
−80 °C until assayed.
DNA extraction and sequencing
Genomic DNA was extract from the samples using the
Quick-gDNA MicroPrep kit (Zymo Research, Irvine,
CA, USA) and 50 μL (10 mg/ml) of lysozyme per sample
for maximal bacterial cell lysis. All procedures were
completed in a laminar flow hood with RNase free mate-
rials. The quantity and quality of DNA was measured
using a spectrophotometer method (Tecan, Männedorf,
Switzerland).
The primers 515 F (5′-GTGCCAGCMGCCGCGGT
AA-3′) and 806R (5′-GGACTACHVGGGTWTCTAAT
−3′) which target the hypervariable V4 region of the 16S
rRNA gene were used for amplification [74] followed by
gel purification and ethanol precipitation to remove any
remaining contaminants and PCR artifacts and subjected
to Illumina MiSeq Plataform at the Next-Generation Se-
quencing Core of University of Pennsylvania.
Microbiological analysis
Taxonomy was assigned using “Quantitative Insights
Into Microbial Ecology” (QIIME) software package [75]
with UCLUST against CORE [76]. Alpha rarefaction was
performed using the Observed Species and Chao1
metrics. Beta diversity was calculated using UniFrac.
Quantification of total bacterial load was determined by
real-time PCR using universal primers for 16S rRNA
gene (F:AGAGTTTGATCCTGGCTCAG; R: ACGGCT
ACCTTGTTACGACTT) (IDT, Coralville, Iowa, USA).
Cytokines measurement
Analyses of IL-6 and IL-17 cytokines were determined
using a BD CBA Human Th1/Th2/Th17 Cytokine Kit
(Becton, Dickinson and Company, BD Biosciences, San
Diego, CA) and analyzed on a BD FACSCalibur flow
cytometer (Becton, Dickinson and Company). The
concentration of the cytokine IL-33 were measured by
enzyme-linked immunosorbent assay (ELISA) using com-
mercially available kits (R&D Systems, Minneapolis, MN,
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USA). The assays were performed according to the manu-
facturer’s instructions. The results were expressed as pico-
grams of cytokines and adjusted accordingly salivary flux
for salivary samples.
Statistics
Clinical, demographic, alpha diversity, and bacterial load
data were compared using Kruskal-Wallis test with
Dunn’s post hoc test. PERMANOVA was performed to
compare beta diversity. Correlations between relative
abundance of taxa and clinical parameters of periodontal
disease and SLE were calculated using Spearman correl-
ation coefficients. For co-occurrence analysis Spearman
rank correlation was calculated with cutoff value of rho
≥0.4 and p < 0.05 as previously described [77]. Relative
abundances of Operation Taxonomy Units (OTU) were
compared among SLE and control subjects and tested
for statistical significance using DESeq2 [78] and LEfSe
[31]. Briefly, LEfSe is a metagenomic biomarker-
discovery approach based on an algorithm that first
performs a nonparametric Kruskal-Wallis test in order
to identify bacterial taxa whose relative abundance is
significantly different in a group of interest compared to
controls. Subsequently, LEfSe applies linear discriminant
analysis (LDA) to those bacterial taxa identified as sig-
nificantly different (p < 0.05) and further assesses the
effect size of each differentially abundant taxon. Only
those taxa that obtain a log LDA score 2 are ultimately
considered. As a result, LEfSe indicates those taxa and
OTUs that better discriminate groups. P values <0.05
were considered to indicate statistical significance.
Additional files
Additional file 1: Table S1. Levels of inflammatory cytokines in serum
of control subjects and SLE patients. (XLSX 9 kb)
Additional file 2: Table S2. OTU table. (TXT 278 kb)
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